Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Celldex Therapeutics Inc
CLDXCurrent price
23.78 USD
+0.77 USD (+3.35%)
Last closed
22.76 USD
Company
www.celldex.com
ISIN
US15117B2025
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 738 218 112 USD
Yield for 12 month
-40.49 %
1Y
3Y
5Y
10Y
15Y
CLDX
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey. Address: Perryville III Building, Hampton, NJ, United States, 08827
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
67.10 USDP/E ratio
–Dividend Yield
–Current Year
+6 883 000 USD
Last Year
+2 357 000 USD
Current Quarter
+3 191 000 USD
Last Quarter
+2 498 000 USD
Current Year
+3 875 000 USD
Last Year
+957 000 USD
Current Quarter
+3 191 000 USD
Last Quarter
+1 701 000 USD
Key Figures CLDX
1 year
3 years
5 years
10 years
EBITDA
-171 060 992 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-19.73 %
PEG Ratio
–
Return On Equity TTM
-29.84 %
Wall Street Target Price
67.10 USD
Revenue TTM
9 976 000 USD
Book Value
11.85 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
110.30 %
Dividend Yield
–
Gross Profit TTM
-79 901 000 USD
Earnings per share
-2.58 USD
Diluted Eps TTM
-2.58 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CLDX
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History CLDX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:15
Payout Ratio
–
Last Split Date
11.02.2019
Dividend Date
11.02.2019
Stock Valuation CLDX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
93.51
Price Sales TTM
174.24
Enterprise Value EBITDA
-17.34
Price Book MRQ
2.15
Financials CLDX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CLDX
For 52 weeks
22.93 USD
53.18 USD
50 Day MA
27.33 USD
Shares Short Prior Month
7 834 833
200 Day MA
35.83 USD
Short Ratio
6.61
Shares Short
7 701 959
Short Percent
13.43 %
BeatStart